Carol is the Chair of Reed Smith's Life Sciences Health Industry Group, practicing in the area of health care regulatory law. She also serves as a member of the firm's Executive Committee. Since joining the firm in 1984, she has practiced exclusively in health care law, providing ongoing counseling on regulatory and legislative initiatives affecting life sciences and health care companies, including Medicare and Medicaid coverage and reimbursement issues, survey and certification, and contractual arrangements. In addition, she has extensive experience in the fraud and abuse area advising clients on business transactions and arrangements for compliance with physician self-referral and anti-kickback laws, and representing clients in criminal and civil proceedings and investigations. Carol also advises pharmaceutical and medical device manufacturers, providers and suppliers to develop and implement corporate compliance programs and comply with Corporate Integrity Agreements (CIAs). She also assists public companies prepare filings with the Securities and Exchange Commission (SEC).
Carol specializes in advising clients on the regulatory requirements and business considerations in connection with health care transactions. She has represented issuers in public offerings, companies and investors in financing transactions, and buyers and sellers in major acquisitions in the life sciences and health care industry, focusing on due diligence, change of ownership (CHOW) issues, regulatory approvals and related regulatory issues.